Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to compare the efficacy of andecaliximab (GS-5745) versus placebo in combination with modified fluorouracil (5-FU), leucovorin (LV), and oxaliplatin (OXA) (mFOLF...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Gilead Sciences
NCT05977998 · Gastric Adenocarcinoma, Carcinomatosis
NCT01717924 · Signet Ring Cell Gastric Adenocarcinoma
NCT06340711 · Esophageal Adenocarcinoma, Gastric Adenocarcinoma, and more
NCT05514769 · Proximal Gastric Adenocarcinoma, Gastric Cancer, and more
NCT06901531 · Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, and more
Scripps Green Hospital
La Jolla, California
University of Southern California
Los Angeles, California
UCLA Jonsson Comprehensive Cancer Center
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions